
Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI/stents) are the two revascularization strategies for coronary artery disease. CABG creates new pathways around blocked arteries using grafts, while PCI opens blockages from inside using balloon-expandable stents. The choice between them is one of the most studied questions in cardiology, with landmark trials providing clear guidance based on disease complexity, diabetes status, and patient factors.
CABG creates bypass grafts around blocked coronary arteries using the left internal mammary artery (LIMA), saphenous vein, or radial artery. It requires sternotomy and cardiopulmonary bypass (or can be performed off-pump). CABG treats the entire length of diseased arteries, not just focal blockages.
PCI uses a catheter threaded through the femoral or radial artery to reach blocked coronary arteries. A balloon is inflated to open the blockage, and a drug-eluting stent is deployed to keep the artery open. The procedure is minimally invasive with no chest incision.
The 2021 ACC/AHA Coronary Revascularization Guidelines recommend CABG for left main disease with high SYNTAX score (Class I), three-vessel disease (Class I), and diabetic patients with multivessel disease (Class I). PCI is recommended for single-vessel disease (Class I) and left main disease with low SYNTAX score (Class IIa). Heart Team discussion is recommended for all complex coronary disease decisions.
The CABG vs PCI decision exemplifies why the Heart Team approach matters. A surgeon evaluates bypass targets, graft quality, and operative risk. A cardiologist evaluates lesion complexity, stent feasibility, and medical therapy optimization. The SYNTAX score provides an objective anatomical measure, but clinical judgment — incorporating diabetes, ejection fraction, completeness of revascularization, and patient preferences — ultimately determines the best strategy.
For complex coronary artery disease (3-vessel, left main, diabetic multivessel), CABG provides superior long-term outcomes. For simpler disease (1-2 vessel, low SYNTAX score), PCI offers equivalent outcomes with less invasive recovery. The SYNTAX score, diabetes status, and ejection fraction are the key factors. A Heart Team evaluation ensures the right strategy for your specific anatomy.
For complex coronary disease (3-vessel, left main, diabetes with multivessel disease), CABG provides better long-term outcomes. For simpler disease, PCI provides equivalent outcomes with faster recovery. The answer depends on your specific anatomy and risk factors.
Modern drug-eluting stents have low restenosis rates, but 15-25% of patients need additional revascularization within 5 years. CABG using the LIMA graft has 90%+ patency at 10 years.
You can, but the FREEDOM trial showed that diabetic patients with multivessel disease do significantly better with CABG. This is a Class I guideline recommendation. Discuss with your Heart Team.
Our Heart Team evaluates your specific anatomy, risk factors, and goals to recommend the best approach. 48-hour turnaround.